Masatomo Miura

23PUBLICATIONS
17CO-AUTHORS
AutoimmunityLife cycle assessment and industrial ecologyAnalytical spectrometryTraditional Chinese medicine and treatmentsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 15, 2026
Everolimus-Involving Immunosuppression Attenuates Renal Interstitial Fibrosis Through Modulation of Mammalian Target of Rapamycin-Related Signal Transduction.

|Apr 09, 2026
Drug Interaction Between Erlotinib and Itraconazole in a Patient With Non-Small Cell Lung Cancer.

Hayato Yokota, Satoshi Goshima, Yuji Okuda

|Nov 21, 2025
Development and Validation of a Novel High-Performance Liquid Chromatography Assay with Ultraviolet Detection for Determination of Asciminib in Human Plasma.

Masatomo Miura, Naoto Takahashi

|Dec 01, 2024
Effects of the Japanese Kampo Medicines Rikkunshito, Shakuyakukanzoto and Goreisan on Lenvatinib Plasma Concentrations in Japanese Patients with Thyroid Cancer.

Kazuma Fujita, Akifumi Suzuki, Mitsuji Nagahama

|Sep 28, 2023
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety.

Tatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa

|Jul 27, 2023
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic-pharmacokinetic and exposure-response analysis.

Hayato Yokota, Kazuhiro Sato, Sho Sakamoto

Pageof 4

Frequent Collaborators

5 joint publications

Yumiko Akamine

5 joint publications

Hayato Yokota

4 joint publications

Naoto Takahashi

1 joint publications

Shotaro Kato